A brief reflection on the past year and some spurious predictions for hc/bio in 2023

October 2022

Ignoring supply chain chokepoints at our own peril.

August 2022

Some offbeat thoughts on why we love public displays of affliction.

May 2022

Been a minute since my last post but I won’t belabor why. Work is challenging (in a fulfilling way) and I’ve started dating again (fun!). My roommates…

December 2021

I’m finally back in the States after a few months of purposeful exploration in Berlin. Armed with speculations on the future of healthcare and bio, my…
In the early months of the pandemic-that-never-ends, I found myself on a Telegram channel for the Fatum Project. Strangers swapped stories about…

November 2021

“At some point, I switched to intellectual production from intellectual consumption.” I stop stirring the spoon in my latte. I am at breakfast with…
Bom Dia! I started writing this issue with my feet still dusted in Portugese sand. I was at a retreat for Other Internet, a research group that develops…

October 2021

Welcome back. It feels surreal to be writing this dispatch from Berlin, home of the Robert Koch Institute (where the eponymous doctor / Nobel…
Plus the Medicare money machine, epigenetic age vs chronological age, ancient medicinal clay, analogies between deep learning and biology

September 2021

Hey there 👋 I’m back after a long writing hiatus. To update those who don’t know, I left venture to join Truepill and help build the API infrastructure…

October 2020

On the back of GoodRx’s IPO (and Steve Hardgrove’s great breakdown on its drug pricing arbitrage business model), I wanted to dig into another relevant…